Opus Point Partners, LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Opus Point Partners, LLC
CIK #0001503454, 0001600175
CIK Period
0001503454 0001600175
Sector Form 13F Holdings Value ($M)
Mettler Toledo International INC/ 2.3
Bristol Myers Squibb Co 1.7
Illumina Inc 1.4
Vertex Pharmaceuticals Inc / Ma 1.4
ISIS Pharmaceuticals Inc 1.2
Alnylam Pharmaceuticals Inc 1.1
Qiagen NV 1.0
Coronado Biosciences Inc 0.9
Proqr Therapeutics NV 0.8
Incyte Corp 0.8
Exact Sciences Corp 0.8
Regeneron Pharmaceuticals Inc 0.7
BioMarin Pharmaceutical Inc 0.7
Ascendis Pharma A/S 0.6
Uniqure NV 0.6
CRISPR Therapeutics AG 0.5
Amarin Corp PLC UK 0.5
Boundless Bio Inc 0.5
Biohaven Ltd 0.5
 
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2025
3 [0001503454]
SC 13D [0001503454]
SC 13G [0001503454]
13F-HR [0001600175]
Form 13D/13G Filer Form 13D/13G Subject Filed
Opus Point Partners LLC Anthera Pharmaceuticals Inc [2012-08-27]
Opus Point Partners LLC Manhattan Pharmaceuticals Inc [2012-01-10]
Form 3/4/5 Subject 2011 - 2025
National Holdings Corp
Rosenwald Lindsay A MD
Fortress Biotech, Inc.
FBIO Acquisition, Inc.
Weiss Michael S
Opus Point Healthcare Innovations (Offshore) Fund Ltd.
Opus Point Partners, LLC
TG Therapeutics Inc
Terms | Privacy | Guide
tony@aum13f.com